Investor mix
9 investors on record; lead investors include Cenova, Lilly Asia Ventures, GL Ventures, Quan Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 33% |
| Private equity | 3 | 33% |
| Bank & private debt | 1 | 11% |
| Other / undisclosed | 2 | 22% |
Developer of therapeutics for ocular disorders
9 investors on record; lead investors include Cenova, Lilly Asia Ventures, GL Ventures, Quan Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 33% |
| Private equity | 3 | 33% |
| Bank & private debt | 1 | 11% |
| Other / undisclosed | 2 | 22% |